Racial differences in sensitivity of blood pressure to aldosterone

Hypertension

Volumn 63, Issue 6, 2014, Pages 1212-1218

  Tu, Wanzhu ^a,b   Eckert, George J ^a   Hannon, Tamara S ^a   Liu, Hai ^a   Pratt, Linda M ^a   Wagner, Mary Anne ^a,c   DiMeglio, Linda A ^a   Jung, Jeesun ^a,d   Pratt, J Howard ^a,c  

^a Department of Biostatistics ^*  (United States)

^b REGENSTRIEF INSTITUTE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Aldosterone; Blood pressure; Child; Continental population groups; Renin; Sodium

Indexed keywords

ALDOSTERONE; BRAIN NATRIURETIC PEPTIDE; FLUDROCORTISONE; POTASSIUM; RENIN;

ADOLESCENT; ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; ARTICLE; BLACK PERSON; BLOOD PRESSURE; BODY MASS; CAUCASIAN; CHILD; COHORT ANALYSIS; ELECTROLYTE EXCRETION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERALDOSTERONISM; INTERVENTION STUDY; MALE; NORMAL HUMAN; OBSERVATIONAL STUDY; PHYSICAL SENSITIVITY; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; SODIUM BALANCE; WEIGHT GAIN;

ALDOSTERONE; BLOOD PRESSURE; CHILD; CONTINENTAL POPULATION GROUPS; RENIN; SODIUM;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ALDOSTERONE; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLUDROCORTISONE; HUMANS; HYPERTENSION; MALE; PROSPECTIVE STUDIES; RENIN; RISK FACTORS; YOUNG ADULT;

EID: 84902265560     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02989     Document Type: Article

References (28)

1. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-2050.
2. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982;306:1276-1279.
3. Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, Woo D, Szaflarski J, Gebel J, Moomaw C, Pancioli A, Jauch E, Shukla R, Broderick J. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke. 2004;35:426-431.
4. Helmer OM, Judson WE. Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosternosm. Circulation. 1968;38:965-976.
5. Wilson DK, Bayer L, Krishnamoorthy JS, Ampey-Thornhill G, Nicholson SC, Sica DA. The prevalence of salt sensitivity in an African-American adolescent population. Ethn Dis. 1999;9:350-358.
6. Luft FC, Miller JZ, Grim CE, Fineberg NS, Christian JC, Daugherty SA, Weinberger MH. Sodium sensitivity and resistance of blood pressure. Age and race as factors in physiological response. Hypertension. 1991;17 (suppl 1):1102-1108.
7. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. 1996;27(3 Pt 2):481-490.
8. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM; Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-3281.
9. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403-1419.
10. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med. 2004;351:33-41.
11. Kotchen TA, E-Gharbawy A, Nadig V, Kotchen JM, Grim CE, Hamet P, Gaudet D. Aldosterone contributes to blood pressure and left ventricular mass in hypertensive African Americans. J Hypertens. 2000;8(suppl 4):S5.
12. El-Gharbawy AH, Nadig VS, Kotchen JM, Grim CE, Sagar KB, Kaldunski M, Hamet P, Pausova Z, Gaudet D, Gossard F, Kotchen TA. Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. Hypertension. 2001;37:845-850.
13. Grim CE, Cowley AW Jr, Hamet P, Gaudet D, Kaldunski ML, Kotchen JM, Krishnaswami S, Pausova Z, Roman R, Tremblay J, Kotchen TA. Hyperaldosteronism and hypertension: ethnic differences. Hypertension. 2005;45:766-772.
14. Huan Y, Deloach S, Keith SW, Goodfriend TL, Falkner B. Aldosterone and aldosterone: renin ratio associations with insulin resistance and blood pressure in African Americans. J Am Soc Hypertens. 2012;6:56-65.
15. Murro DG, Beavers M, Harshfield GA, Kapuku GK. Aldosterone contributes to elevated left ventricular mass in black boys. Pediatr Nephrol. 2013;28:655-660.
16. Pratt JH, Jones JJ, Miller JZ, Wagner MA, Fineberg NS. Racial differences in aldosterone excretion and plasma aldosterone concentrations in children. N Engl J Med. 1989;321:1152-1157.
17. Fisher ND, Gleason RE, Moore TJ, Williams GH, Hollenberg NK. Regulation of aldosterone secretion in hypertensive blacks. Hypertension. 1994;23:179-184.
18. Ripley E, King K, Sica DA. Racial differences in response to acute dosing with hydrochlorothiazide. Am J Hypertens. 2000;13:157-164.
19. Tu W, Eckert GJ, DiMeglio LA, Yu Z, Jung J, Pratt JH. Intensified effect of adiposity on blood pressure in overweight and obese children. Hypertension. 2011;58:818-824.
20. Baughman KL. B-type natriuretic peptide - a window to the heart. N Engl J Med. 2002;347:158-159.
21. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904-909.
22. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555-576.
23. Hastie T, Tibshirani R. Varying-coefficient models. J Roy Stat Soc B. 1993;55:757-796.
24. Granger JP, Alexander BT, Llinas M. Mechanisms of pressure natriuresis. Curr Hypertens Rep. 2002;4:152-159.
25. McDonough AA. Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2010;298: R851-R861.
26. Saha C, Eckert GJ, Ambrosius WT, Chun TY, Wagner MA, Zhao Q, Pratt JH. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension. 2005;46:481-487.
27. Flack JM, Oparil S, Pratt JH, Roniker B, Garthwaite S, Kleiman JH, Yang Y, Krause SL, Workman D, Saunders E. Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. J Am Coll Cardiol. 2003;41:1148-1155.
28. Brown NJ. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol. 2013;9:459-469.